Noven Announces Third Quarter Earnings Release Date

-- On November 9, before the market opens, Noven is scheduled to issue a press release announcing its financial results for the quarter ended September 30, 2004. At 11:00 a.m. Eastern Time the same day, a conference call among management and analysts will be broadcast live via the Internet at www.noven.com, and thereafter a rebroadcast will be accessible at the same site. A taped replay of the call will be available beginning in the afternoon of November 9 through November 11 by calling 877-660-6853 (from within the U.S.) or 201-612-7415 (from outside the U.S.) and entering the account #1628 and the conference ID #119983.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven's prescription patches are sold in over 30 countries, and a range of new patches are being investigated and developed in collaboration with Novartis Pharma AG, Shire Pharmaceuticals Group plc, P&G Pharmaceuticals, Endo Pharmaceuticals Inc. and others. With the most advanced and broadly applicable transdermal technology in its class, Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. See www.noven.com for additional information.

Contact:
Alina Canales
Investor Relations Coordinator
Noven Pharmaceuticals, Inc.
305-253-1916